Welcome to our dedicated page for Agape Atp news (Ticker: atpc), a resource for investors and traders seeking the latest updates and insights on Agape Atp stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Agape Atp's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Agape Atp's position in the market.
Agape ATP Corporation (NASDAQ:ATPC) announced a 1-for-50 reverse stock split of its issued and outstanding common stock, approved by shareholders on January 30, 2026, and expected to become effective February 9, 2026.
The company’s common stock will trade on a reverse split-adjusted basis on the Nasdaq at the open on February 10, 2026, retaining the symbol ATPC. No fractional shares will be issued; fractions will be rounded up. The reverse split will not change the authorised share count. A new CUSIP 008389306 will be assigned and outstanding equity awards will be adjusted proportionately.
Agape ATP Corporation (NASDAQ:ATPC) announced it received a Nasdaq notification about potential delisting after failing to meet minimum bid-price rules.
Nasdaq found ATPC out of compliance with Rule 5550(a)(2) and determined delisting under Rule 5810(c)(3)(A)(iii) was possible after a closing bid at or below $0.10 for ten consecutive trading days.
The company intends to request a hearing by 9 February 2026 to appeal; filing the hearing request will stay suspension of trading and Form 25-NSE while the appeal is pending.
Agape ATP Corporation (NASDAQ:ATPC) received a Nasdaq notice on January 27, 2026 that it is not in compliance with the minimum $1.00 bid price requirement under Nasdaq Listing Rule 5550(a)(2).
The company has an initial 180-calendar-day compliance period until July 27, 2026 to regain compliance. Trading will continue under the symbol ATPC. The company said it is evaluating options, which may include a reverse stock split, and cautioned there is no assurance of regaining compliance.
Agape ATP Corporation (NASDAQ:ATPC) has formed a strategic three-way partnership with Global Strategic Solutions LLC (GSS) and BM Trading Services Company Limited (BMT) to advance energy and infrastructure initiatives in emerging markets. The partnership, which includes an initial three-year exclusivity period with automatic one-year renewals, combines ATPC's engineering and construction capabilities with GSS's strategic advisory expertise and BMT's local Vietnamese market presence.
The collaboration will focus on petroleum trade, energy transition, and infrastructure development across Southeast Asia, Africa, and Eastern Europe. ATPC will provide engineering and construction services, while GSS will handle project identification and strategy, and BMT will facilitate commercial operations in Vietnam, particularly in sectors including diesel, jet fuel, hybrid energy, and logistics infrastructure.
Agape ATP (NASDAQ: ATPC) has secured two significant Sales and Purchase Agreements (SPAs) with Swiss One Oil & Gas AG, valued at approximately USD 24 billion. The agreements follow a successful February 2025 Initial Corporate Purchase Order (ICPO) for trial shipments.
The SPAs outline a 12-month supply arrangement with potential extensions, starting with a trial order of 200,000 metric tonnes of EN590 10PPM diesel and 2 million barrels of Jet Fuel A1 in March 2025. Upon successful completion, the agreement scales to weekly deliveries of 500,000 metric tonnes of diesel and 2 million barrels of Jet Fuel A1.
Deliveries will be executed through Free on Board (FOB) procedures at major international ports, with SGS or equivalent authorities conducting quality assessments to ensure compliance with ASTM/IP international standards.
Agape ATP (ATPC) has successfully completed a $23 million private placement, issuing 46 million shares of common stock at $0.50 per share under Regulation S to non-U.S. investors. The capital raised will support the company's expansion initiatives across multiple sectors.
The funding will be allocated to advance oil & gas trading projects, particularly through its partnership with Swiss One Oil & Gas AG for refined fuel products distribution, including EN590 10PPM diesel and Jet Fuel A1. Additionally, ATPC plans to scale up its solar energy ventures and enhance its healthcare and wellness solutions, focusing on product innovation, regulatory approvals, and commercialization efforts.
Agape ATP (ATPC) has secured a $23 million private placement from institutional investors, involving the issuance of 46 million shares at $0.50 per share to 18 institutional investors under Regulation S. The transaction is expected to close within 30 business days.
The funding will support ATPC's expansion in healthcare, oil & gas trading, and renewable energy sectors. The company recently partnered with Swiss One Oil & Gas AG for large-scale fuel procurement, including EN590 10PPM diesel and Jet Fuel A1.
Following the placement, ATPC's total issued shares will increase from 4,005,381 to 50,005,381. The company will file a registration statement with the SEC within 45 days for the newly issued shares.
ATPC has signed an Irrevocable Corporate Purchase Order (ICPO) with Swiss One Oil & Gas AG for 200,000 metric tons of EN590 10PPM diesel and 2,000,000 barrels of Jet Fuel A1 in an initial trial phase. The strategic partnership aims to enhance oil and gas sales operations by combining ATPC's expertise in sustainable business strategies with Swiss One's experience in the oil and gas sector.
The collaboration focuses on optimizing supply chain efficiency through resource sharing, streamlined logistics, and integration of advanced technologies for inventory management and shipment tracking. Both companies will work together to expand market presence, improve operational efficiency, and implement environmentally responsible practices.
The partnership represents a significant step in ATPC's diversification strategy in the global energy sector, with both companies expected to benefit from increased market presence, cost efficiencies, and new trading opportunities.
ATPC has signed three Memorandums of Understanding (MOUs) with prominent Indonesian healthcare institutions to advance medical research and treatment strategies for respiratory diseases. The partnerships with Dr. Sardjito General Hospital, Dr. H. A. Rotinsulu Lung Hospital, and Dr. M. Goenawan Partowidigdo Respiratory Hospital focus on enhancing research capabilities, conducting clinical studies on ATPC's health products, and ensuring compliance with Indonesian health standards. The collaboration aims to address tuberculosis (TB) and chronic obstructive pulmonary disease (COPD), major health concerns in Indonesia, through advanced medical research, healthcare professional training, and innovative treatment approaches.
NASDAQ-listed Agape ATP (ATPC) unveils its six core business pillars aimed at addressing global challenges in sustainability, health, and quality of life. The pillars include:
1. ATPC Green Energy (AGE): Focuses on sustainable energy solutions and energy-saving projects in Malaysia and ASEAN countries.
2. Agape Superior Living (ASL): Develops anti-aging supplements like ATP2 for the wellness industry.
3. Cedar ATPC: Offers Myofascial Release Therapy and Pain Relief Therapy for improved physical well-being.
4. Senior Living: Creates supportive environments for elderly care.
5. Medical Devices: Collaborates with FORMEDIC Technologies to develop the LEGA device for respiratory care.
6. DSY Wellness: Provides nutraceuticals and nutritional medicine products.
ATPC aims to synergize these pillars to drive business growth while contributing to global wellness and sustainability.
FAQ
What is the current stock price of Agape Atp (atpc)?
What is the market cap of Agape Atp (atpc)?
